Diaceutics, London Genetics to Develop Informatics Solution for Biomarker Research

According to the partners, the software, which is based on Diaceutics Fusion platform, will help commercial companies build biomarker hypotheses, request expressions of interest, and prepare proposals for clinical development.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.